Pre-transplantation thymic function is associated with the risk of acute graft versus host disease and cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation

References

• Singh AK, McGuirk JP. Allogeneic stem cell transplantation: a historical and scientific overview. Cancer Res. 2016 Nov 15;76(22):6445–6451.
   Web of Science ®Google Scholar
• Brown JA, Stevenson K, Kim HT, et al. Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. Blood. 2010;115:4111–4119. doi: 10.1182/blood-2009-09-244145
   PubMed Web of Science ®Google Scholar
• Geddes M, Storek J. Immune reconstitution following hematopoietic stem-cell transplantation. Best Pract Res Clin Haematol. 2007 Jun;20(2):329–348. doi: 10.1016/j.beha.2006.09.009
   PubMed Web of Science ®Google Scholar
• Lilleri D, Gerna G, Fornara C, et al. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood. 2006 Aug 15;108(4):1406–1412. doi: 10.1182/blood-2005-11-012864
   PubMed Web of Science ®Google Scholar
• Toubert A, Glauzy S, Douay C, et al. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again. Tissue Antigens. 2012 Feb;79(2):83–89. doi: 10.1111/j.1399-0039.2011.01820.x
   PubMedGoogle Scholar
• Hakim FT, Gress RE. Reconstitution of thymic function after stem cell transplantation in humans. Curr Opin Hematol. 2002 Nov;9(6):490–496. doi: 10.1097/00062752-200211000-00004
   PubMed Web of Science ®Google Scholar
• Hochberg EP, Chillemi AC, Wu CJ, et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood. 2001;98(4):1116–1121. doi: 10.1182/blood.V98.4.1116
   PubMed Web of Science ®Google Scholar
• Dion ML, Sekaly RP, Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol. 2007;380:197–213. doi: 10.1007/978-1-59745-395-0_12
   PubMedGoogle Scholar
• Ringhoffer S, Rojewski M, Dohner H, et al. T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/TREC ratio and thymic naive T cells. Haematologica. 2013 Oct;98(10):1600–1608. doi: 10.3324/haematol.2012.072264
   PubMed Web of Science ®Google Scholar
• de Villartay J-P, Hockett RD, Korsmeyer SJ, et al. Deletion of the human T-cell receptor δ-gene by a site-specific recombination. 1988.
   Google Scholar
• Takeshita S, Toda M, Yamagishi H. Excision products of the T cell receptor gene support a progressive rearrangement model of the alpha/delta locus. EMBO J. 1989 Nov;8(11):3261–3270.
   PubMed Web of Science ®Google Scholar
• Poulin JF, Viswanathan MN, Harris JM, et al. Direct evidence for thymic function in adult humans. J Exp Med. 1999 Aug 16;190(4):479–486. doi: 10.1084/jem.190.4.479
   PubMed Web of Science ®Google Scholar
• Kimmig S, Przybylski GK, Schmidt CA, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med. 2002;195(6):789–794. doi: 10.1084/jem.20011756
   PubMed Web of Science ®Google Scholar
• Kohler S, Thiel A. Life after the thymus: CD31+ and CD31-human naive CD4+ T-cell subsets. Blood. 2009 Jan 22;113(4):769–774. doi: 10.1182/blood-2008-02-139154
   PubMed Web of Science ®Google Scholar
• Chen X, Barfield R, Benaim E, et al. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood. 2005 Jan 15;105(2):886–893. doi: 10.1182/blood-2004-04-1405
   PubMed Web of Science ®Google Scholar
• Clave E, Rocha V, Talvensaari K, et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2005 Mar 15;105(6):2608–2613. doi: 10.1182/blood-2004-04-1667
   PubMed Web of Science ®Google Scholar
• Wils EJ, van der Holt B, Broers AE, et al. Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients. Haematologica. 2011 Dec;96(12):1846–1854. doi: 10.3324/haematol.2011.047696
   PubMed Web of Science ®Google Scholar
• Sairafi D, Mattsson J, Uhlin M, et al. Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival. Clin Immunol. 2012 Mar;142(3):343–350. doi: 10.1016/j.clim.2011.12.001
   PubMed Web of Science ®Google Scholar
• Clave E, Lisini D, Douay C, et al. Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse. Front Immunol. 2013;4:54. doi: 10.3389/fimmu.2013.00054
   PubMed Web of Science ®Google Scholar
• Uzunel M, Sairafi D, Remberger M, et al. T-cell receptor excision circle levels after allogeneic stem cell transplantation are predictive of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome. Stem Cells Dev. 2014 Jul 15;23(14):1559–1567. doi: 10.1089/scd.2013.0588
   PubMed Web of Science ®Google Scholar
• Deeg HJ, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med. 1984;35:11–24. doi: 10.1146/annurev.me.35.020184.000303
   PubMed Web of Science ®Google Scholar
• Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003 Apr;9(4):215–233. doi: 10.1053/bbmt.2003.50026
   PubMed Web of Science ®Google Scholar
• Sottini A, Ghidini C, Zanotti C, et al. Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin Immunol. 2010 Aug;136(2):217–227. doi: 10.1016/j.clim.2010.04.005
   PubMed Web of Science ®Google Scholar
• Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998 Dec 17;396(6712):690–695. doi: 10.1038/25374
   PubMed Web of Science ®Google Scholar
• Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012 May 11;12(6):443–458. doi: 10.1038/nri3212
   PubMed Web of Science ®Google Scholar
• Ball LM, Egeler RM, Party EPW. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant. 2008 Jun;41(Suppl 2):S58–S64. doi: 10.1038/bmt.2008.56
   PubMed Web of Science ®Google Scholar
• Teshima T, Reddy P, Liu C, et al. Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood. 2003 Jul 15;102(2):429–435. doi: 10.1182/blood-2003-01-0266
   PubMed Web of Science ®Google Scholar
• Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol. 2008 Dec;8(12):948–957. doi: 10.1038/nri2450
   PubMed Web of Science ®Google Scholar
• Dertschnig S, Hauri-Hohl MM, Vollmer M, et al. Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD. Blood. 2015 Apr 23;125(17):2720–2723. doi: 10.1182/blood-2014-08-597245
   PubMed Web of Science ®Google Scholar
• Reubsaet LL, de Pagter AP, van Baarle D, et al. Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease. Bone Marrow Transplant. 2013 Apr;48(4):502–507. doi: 10.1038/bmt.2012.174
   PubMed Web of Science ®Google Scholar
• Johnson BD, Konkol MC, Truitt RL. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant. 2002;8(10):525–535. doi: 10.1053/bbmt.2002.v8.pm12434947
   PubMed Web of Science ®Google Scholar
• Miura Y, Thoburn CJ, Bright EC, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood. 2004 Oct 1;104(7):2187–2193. doi: 10.1182/blood-2004-03-1040
   PubMed Web of Science ®Google Scholar
• Cohen JL, Trenado A, Vasey D, et al. CD4+ CD25+ immunoregulatory T cells new therapeutics for graft-versus-host disease. J Exp Med. 2002;196(3):401–406. doi: 10.1084/jem.20020090
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Ermann J, Edinger M, et al. Donor-type CD4+ CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196(3):389–399. doi: 10.1084/jem.20020399
   PubMed Web of Science ®Google Scholar
• Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493–3499. doi: 10.1182/blood.V99.10.3493
   PubMed Web of Science ®Google Scholar
• Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor FOXP3-positive regulatory T-cell (treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006 Aug 15;108(4):1291–1297. doi: 10.1182/blood-2006-02-003996
   PubMed Web of Science ®Google Scholar